Galectin-1-targeted TA nanoprobe was composed of Gal1 antibody for targeting pancreatic tumors and a microwave absorber of Fe3O4 nanoparticles for enhancing TA signal. The gene discussed is LGALS1; the disease is pancreatic neoplasm.